As a leading global medicines company, our primary contribution is to discover innovative solutions to tackle and prevent diseases, to ease suffering and to improve quality-of-life.
Expanding access to healthcare is a goal Novartis shares with valued partners within governments, private companies, NGOs and key healthcare bodies. Barriers to access can be overcome only with effective and coordinated action by everyone involved. By working together, we can achieve our common goal.
At Novartis, expanding access begins with medical research, continues with product donations and new ways of doing business, and is supported by working hand in hand with partners to strengthen healthcare in both developing and advanced economies.
Ground-breaking advances in medicine are only meaningful if they reach the people who need them.
Our expanding access to healthcare programmes is valued at over USD 2 billion. In 2016, our programmes reached 8.9 million people with a particular focus on improving cardiovascular health in urban settings and leprosy elimination. Millions more purchase high-quality, low-cost generics from our Sandoz division.